Search for Clinical Trial Results

Sponsored By

Coagulation Protein Disorders - 7 Studies Found

Status Study
Completed Study Name: Observational Study of Prophylaxis and Treatment of Acute Perioperative Bleeding With Beriplex® P/N (Probe Study)
Condition:
  • Coagulation Protein Disorders
  • Blood Loss, Surgical
  • Date: 2010-01-20
    Interventions:
    • Biological: Beriplex® P/N

Enrolling by invitation Study Name: A Study of ProMetic Plasminogen IV Infusion in Subjects With Hypoplasminogenemia
Condition: Hypoplasminogenemia
Date: 2016-02-12
Interventions: Biological: Plasminogen (human) intravenous ProMetic Plasminogen(human) intravenous
Completed Study Name: A Phase 1 Study of ProMetic Plasminogen (Human) Intravenous in Adults and Children With Plasminogen Deficiency
Condition:
  • Type I Plasminogen Deficiency
  • Hypoplasminogenemia

Date: 2014-12-04
Interventions: Biological: Plasminogen (Human) Intravenous Plasma-derived purified plasminogen formulated for intraveno
Recruiting Study Name: A Study to Evaluate the Real-world Usage and Effectiveness of Elocta and Alprolix in Patients With Haemophilia A or B
Condition:
  • Haemophilia A
  • Haemophilia B

Date: 2017-02-14
Interventions:
  • Drug: ELOCTA Extended half-lif
Terminated Study Name: Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Congenital Hemophilia A
Condition: Hemophilia A
Date: 2011-09-13
Interventions: Biological: OBI-1 intravenous infusion, up to every 2-3 hours for the first 24 hours of treatment
Completed Study Name: Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A
Condition:
  • Hematologic Disease
  • Blood Coagulation Disorders

Date: 2008-10-29
Interventions:
  • Behavioral: Recombinant Factor VIII (Kogenate, BAY 14-2222)

Completed Study Name: Cooperative Study of Factor VIII Inhibitors
Condition:
  • Blood Coagulation Disorders
  • Hematologic Diseases
  • Hemophili
    Date: 1999-10-27
    Interventions: Drug: factor ix